Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Enterprise Value (2020 - 2025)

Rapid Micro Biosystems' Enterprise Value history spans 6 years, with the latest figure at -$22.4 million for Q3 2025.

  • For Q3 2025, Enterprise Value rose 63.17% year-over-year to -$22.4 million; the TTM value through Sep 2025 reached -$22.4 million, up 63.17%, while the annual FY2024 figure was -$50.7 million, 44.89% up from the prior year.
  • Enterprise Value for Q3 2025 was -$22.4 million at Rapid Micro Biosystems, down from -$13.1 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$100000.0 in Q1 2025 and bottomed at -$219.6 million in Q3 2021.
  • The 5-year median for Enterprise Value is -$65.9 million (2022), against an average of -$73.9 million.
  • The largest annual shift saw Enterprise Value crashed 20177.33% in 2024 before it soared 99.87% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$193.5 million in 2021, then soared by 43.85% to -$108.6 million in 2022, then grew by 15.27% to -$92.1 million in 2023, then surged by 44.89% to -$50.7 million in 2024, then skyrocketed by 55.84% to -$22.4 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Enterprise Value are -$22.4 million (Q3 2025), -$13.1 million (Q2 2025), and -$100000.0 (Q1 2025).